The need for a holistic view on management of Clostridioides difficile infection

Wingen-Heimann, S.M.; Prehn, J. van; Kuijper, E.J.; Vehreschild, M.J.G.T. (2021)

Other

• Bezlotoxumab
• Clostridioides difficile infection
• Cost-effectiveness
• Fidaxomicin
• Prevention of recurrent Clostridioides difficile infection

• All authors: Wingen-Heimann, S.M.; Prehn, J. van; Kuijper, E.J.; Vehreschild, M.J.G.T.
• Date: 2021-10-01
• Title of host publication: Clinical Microbiology and Infection
• Volume: 27
• Issue: 10
• Pages: 1383 - 1385
• DOI: doi:10.1016/j.cmi.2021.07.014
• Link: http://www.clinicalmicrobiologyandinfection.com/article/S1198743X2100406...